SCHEMBL13664435

SCHEMBL13664435

Cc1ccc(C(=O)c2nn(-c3ccc(Cl)cc3)c(NCCCNC(=O)c3ccc(C(F)(F)F)cc3)c2C#N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHOC P08134 2/20 0.43
RHOA P61586 2/20 0.43
MAPT P10636 5/20 0.42
GAA P10253 2/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
THRB P10828 1/20 0.42
AR P10275 2/20 0.40
CNR1 P21554 3/20 0.40
NPC1 O15118 1/20 0.39
CRHR1 P34998 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
NR3C1 P04150 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664143 0.94 POLB (0.46) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664373 0.94 POLB (0.46) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664421 0.93 GAA (0.42) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664403 0.93 L3MBTL1 (0.46) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664437 0.92 RHOC (0.43) RHOCRHOAMAPTGAAPOLB
SCHEMBL13664463 0.92 RHOC (0.42) RHOCRHOAMAPTGAAPOLB
SCHEMBL13664354 0.92 POLB (0.43) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664332 0.92 L3MBTL1 (0.43) MAPTGAAPOLBTDP1L3MBTL1
SCHEMBL13664595 0.92 CNR1 (0.42) RHOCRHOAMAPTGAAPOLB
SCHEMBL13664352 0.91 GAA (0.44) MAPTGAAPOLBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R RHOC 3602/4885RHOA 4704/4885MAPT 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.